tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Advertisement

GlaxoSmithKline (GSK) Technical Analysis

Compare
5,113 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 0.95, suggesting GlaxoSmithKline is a Buy.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 42.86, while GlaxoSmithKline’s (GSK) share price is $43.91, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 41.31, while GlaxoSmithKline’s (GSK) share price is $43.91, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Oct 21, 2025, 12:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
43.09
43.36
43.56
43.83
44.04
44.30
44.51
Fibonacci
43.36
43.54
43.65
43.83
44.01
44.12
44.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Oct 21, 2025, 12:25 AM
Period
Simple
Exponential
MA5
43.86Buy
43.81Buy
MA10
43.66Buy
43.56Buy
MA20
42.72Buy
42.86Buy
MA50
40.90Buy
41.31Buy
MA100
39.66Buy
39.89Buy
MA200
37.78Buy
38.04Buy
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 43.56, while GlaxoSmithKline’s (GSK) share price is $43.91, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 39.89, while GlaxoSmithKline’s (GSK) share price is $43.91, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is $43.91 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 40.90, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $43.91 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 39.66, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $43.91 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 37.78, creating a Buy signal.

GlaxoSmithKline (GSK) Technical Indicators

Oct 21, 2025, 12:25 AM
Name
Value
Implied Action
RSI (14)
62.67
Neutral
STOCH (9,6)
61.88
Neutral
STOCHRSI (14)
63.97
Neutral
MACD (12,26)
0.95
Buy
ADX (14)
28.30
Neutral
Williams %R
-43.75
Buy
CCI (14)
54.48
Neutral
ATR (14)
0.85
-
Ultimate Oscillator
55.17
Neutral
ROC
6.84
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 62.67, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 28.30, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 54.48, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 6.84, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Strong Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 62.67, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 0.95, which suggests GSK is a Buy.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 43.86, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 42.72, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 40.90, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 37.78, which suggests GSK is a Buy.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -43.75, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 54.48, which suggests GSK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis